Counteraction of perforated cecum lesions in rats: Effects of pentadecapeptide BPC 157, L-NAME and L-arginine.
Drmic. Domagoj D; Samara. Mariam M; Vidovic. Tinka T; Malekinusic. Dominik D; Antunovic. Marko M; Vrdoljak. Borna B; Ruzman. Jelena J; Milkovic Perisa. Marija M; Horvat Pavlov. Katarina K; Jeyakumar. Jerusha J; Seiwerth. Sven S; Sikiric. Predrag P
Key Findings
- BPC‑157 dramatically increased new vessel formation at the injury site and narrowed the gut defect within minutes.
- The peptide normalized oxidative stress markers (MDA) and nitric‑oxide levels, unlike control or NO‑system drugs alone.
- Combining BPC‑157 with nitric‑oxide modulators (L‑NAME or L‑arginine) did not diminish its healing benefits and still outperformed the drugs by themselves.
Practical Outcomes
- For biohackers interested in gut health or injury recovery, BPC‑157 shows promise as a fast‑acting wound‑healing agent, likely working through the nitric‑oxide pathway. However, the data are from rats, so human dosing and safety remain uncertain. It suggests that, if you choose to experiment, a low microgram dose (similar to the 10 µg used in rats) could be a starting point, but clinical guidance is needed before regular use.
Summary
In a rat study, a peptide called BPC‑157 helped heal a hole in the gut faster by boosting blood‑vessel growth, reducing bleeding, and keeping oxidative stress low. It worked better than just giving nitric‑oxide‑related drugs alone, and even when combined with those drugs it still showed strong healing effects.
Abstract
To study the counteraction of perforated cecum lesion using BPC 157 and nitric oxide (NO) system agents. Alongside with the agents' application (after 1 min, medication (/kg, 10 mL/2 min bath/rat) includes: BPC 157 (10 μg), L-NAME (5 mg), L-arginine (100mg) alone or combined, and saline baths (controls)) on the rat perforate cecum injury, we continuously assessed the gross reappearance of the vessels (USB microcamera) quickly propagating toward the defect at the cecum surface, defect contraction, bleeding attenuation, MDA- and NO-levels in cecum tissue at 15 min, and severity of cecum lesions and adhesions at 1 and 7 d. Post-injury, during/after a saline bath, the number of vessels was significantly reduced, the defect was slightly narrowed, bleeding was significant and MDA-levels increased and NO-levels decreased. BPC 157 bath: the vessel presentation was markedly increased, the defect was noticeably narrowed, the bleeding time was shortened and MDA- and NO-levels remained normal. L-NAME: reduced vessel presentation but not more than the control, did not change defect and shortened bleeding. L-arginine: exhibited less vessel reduction, did not change the defect and prolonged bleeding. In combination, mutual counteraction occurred (L-NAME + L-arginine) or the presentation was similar to that of BPC 157 rats (BPC 157 + L-NAME; BPC 157 + L-arginine; BPC 157 + L-NAME + L-arginine), except the defect did not change. Thereby at day 1 and 7, saline, L-NAME, L-arginine and L-NAME + L-arginine failed (defect was still open and large adhesions present). The therapeutic effect was achieved with BPC 157 alone or in combination with L-NAME and L-arginine as it was able to consolidate the stimulating and inhibiting effects of the NO-system towards more effective healing recruiting vessels.
Study Information
pubmed
2018
2018-12-28T00:00:00.000Z
10.3748/wjg.v24.i48.5462
38
55